Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Aidigong Maternal & Child Health ( (HK:0286) ) is now available.
Aidigong Maternal & Child Health Limited has announced an update on its efforts to resume trading on the Hong Kong Stock Exchange, which has been suspended since February 2025. The company is facing challenges in finalizing its 2024 annual results due to non-cooperation from key personnel at Shenzhen Aidigong, a subsidiary. Aidigong is working with professional advisers to conduct a forensic investigation and internal control review, aiming to formulate a viable proposal for resumption. The company remains committed to resolving these issues and will provide further updates as necessary.
More about Aidigong Maternal & Child Health
Aidigong Maternal & Child Health Limited operates in the maternal and child health industry, focusing on providing health services and products for mothers and children. The company is incorporated in Bermuda and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 6,000
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$251.6M
See more data about 0286 stock on TipRanks’ Stock Analysis page.